MedPath

Reducing Sedentary Time in Bariatric: The Take a STAND for Health Study

Not Applicable
Conditions
Obesity, Morbid
Bariatric Surgery
Interventions
Behavioral: The Take a STAND for health
Registration Number
NCT04517591
Lead Sponsor
University of Sao Paulo
Brief Summary

This research program aims to comprehensively investigate the clinical, physiological, metabolic, and molecular effects of reducing sedentary behavior in post-bariatric patients. To this aim, we will conduct a crossover trial and a randomized controlled trial. The crossover trial aims to unravel potential mechanisms underlying the metabolic, physiological and molecular effects of breaking up sedentary time with light-intensity physical activity versus carrying out the minimum amount of daily exercise at once and then remaining sedentary versus simply remaining sedentary throughout all sessions, in a well-controlled laboratorial condition. The 4-month parallel-group randomized controlled trials aim to investigate the feasibility and efficacy of a newly developed personalized intervention focused on replacing sedentary time with light- (or very light-) intensity physical activity in these patients. A multitude of gold-standard techniques will be applied to evaluate the effects of the intervention on several outcomes, including sedentary time (primary outcome), physical activity levels, clinical parameters specific to each condition, cardiometabolic risk factors, immune function, and health-related quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

Women aged 20 to 50 years with BMI ≥ 35 kg / m2 and associated comorbidities, or BMI ≥ 40 kg / m2 who are about to undergo Roux-en-Y gastric bypass surgery at the Metabolic and Bariatric Surgery Unit of the Faculty of Medicine.

Exclusion Criteria

Exclusion criteria will involve sedentary time (sitting / reclining) <8 hours per day; anemia; hypothyroidism; current malignancy or history of cancer within the past 5 years; cardiovascular disease; neurological disorders; any physical disabilities that could hamper physical testing; and being physically active (i.e., participation in ≥ 150 minutes per week of moderate-to-vigorous physical activity in bouts of ≥ 10 minutes, or ≥ 75 minutes per week of vigorous-intensity physical activity).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Take a STAND for healthThe Take a STAND for healthA newly developed personalized intervention focused on replacing sedentary time with light-(or very light-) intensity physical activity
Primary Outcome Measures
NameTimeMethod
Change from baseline to follow-up on sedentary behaviour4 months

Sedentary behaviour will be assessed by ActivPAL™

Secondary Outcome Measures
NameTimeMethod
Change from baseline to follow-up on quality of life4 months

Quality of life will be assessed by Bariatric Analysis and Reporting Outcome questionnaire

Change from baseline to follow-up on food intake4 months

Food intake will be assessed by means of three 24-hours food recalls

Change from baseline to follow-up on physical activity levels4 months

Physical activity levels will be assessed by ActiGraph GT3X®

Change from baseline to follow-up on aerobic capacity4 months

Aerobic capacity will be assessed by a maximal cardiopulmonary exercise test

Change from baseline to follow-up on autonomic function4 months

Autonomic function will be assessed by heart rate variability

Change from baseline to follow-up on body composition4 months

Lean mass, fat mass and bone mass will be assessed by densitometry (DEXA)

Change from baseline to follow-up on cardiovascular risk score4 months

Cardiovascular risk score will be assessed by Framingham score

Change from baseline to follow-up on sleep apnea4 months

Sleep apnea will be assessed by polysomnography

Change from baseline to follow-up on office and ambulatory blood pressure4 months (RCT) and 5 hours (crossover)

Office and ambulatory blood pressure will be assessed by automated devices

Change from baseline to follow-up on functional capacity and fatigue4 months

Functional capacity will be assessed by Timed Up-And-Go, Time-Stands and handgrip tests. Fatigue will be assessed by fatigue severity scale and Chalder fatigue scale.

Change from baseline to follow-up on cardiovascular and respiratory chemoreflex control4 months

Cardiovascular and respiratory chemoreflex control will be assessed by hyperoxia and hypoxia protocol

© Copyright 2025. All Rights Reserved by MedPath